Date: January 31, 2007
For Release: IMMEDIATELY
Refer to: (317) 276-5795 - Mark E. Taylor
Lilly Announces 2006 Adjusted EPS of $3.18 Excluding Charges and
Reported EPS of $2.45
Sales grew 9 percent in the fourth quarter and 7 percent for t…
ELI LILLY AND Company has received Food and Drug Administration (FDA) approval for Forteo and Strattera, ahead of early 2003 projections.
The company reiterated full-year 2002 earnings per share (EPS) guidance of $2.55 to $2.57, and continues to be cautious about 2003. Analysts say the new drug launches could aggravate a likely earnings shortfall in 2003.
Most Popular
3 Questions No Job Seeker Ever Wan…
New data suggest that Strattera
(atomoxetine HCl) improved ADHD symptoms in children and adolescents who
had both ADHD and a reading disorder, like dyslexia. Results were
announced today at a meeting of child and adolescent psy…
The Food and Drug Administration has ordered new warning labels concerning the potential for …
Most Popular
SWOT Analysis - To Make Your Business More Profitable
13 Job Interview Mistakes To Avoid
In the interest of the patient: Convergence across the pharmaceutical and healthcare industries
5 Regular Mistakes In Public Speaking
3 Questions No Job Seeker Ever Wants To Be Asked?
Read th…
Business Editors & Health/Medical Writers
ADVISORY…for TUESDAY (Nov. 26)
NOTE TO EDITORS: Multimedia Assets Available With This Story
Include Logos, Text News Releases, Video
–(BUSINESS WIRE)
The U.S. Food and Drug Administration (FDA) today approved Stratter…
Business & Health/Medical Editors
INDIANAPOLIS–(BW HealthWire)–Aug. 14, 2002
Eli Lilly and Company (NYSE:LLY) has received an approvable letter from the U.S. Food and Drug Administration (FDA) for Strattera(TM) (atomoxetine hydrochloride),…
Byline: Julie Robotham
Related Results
Finding …
Most Popular
5 Regular Mistakes In Public Speaking
13 Job Interview Mistakes To Avoid
10 Jobs That Pay $30 An Hour
Public Speaking: 7 Secrets Of Great Public Speakers
3 Questions No Job Seeker Ever Wants To Be Asked?
…
